Digital Changing Faces – Digital and supplier hires – August and Sep... There was plenty of personnel action in August and September among pharmaceutical suppliers, particularly in the clinical trial technology sector.
News Organon CEO resigns over 'improper' contraceptive sales Organon CEO Kevin Ali has stepped down after an audit found sales of the company's Nexplanon contraceptive implant in the US were inflated.
Sales & Marketing Changing Faces – Pharma and biotech hires – August and Septe... It’s been a busy couple of months in the world of pharma hires as Merck KGaA and GSK both made some big changes at the top.
News After FDA exit, Peter Marks pops up at Lilly The ousted former director of CBER, Peter Marks, has joined Eli Lilly as head of molecular discovery and infectious disease research.
News Walmsley to leave GSK in surprise exit This week has kicked off with the news that Emma Walmsley is standing down as chief executive of GSK after eight years, to be replaced by Luke Miels.
News Merck names electronics unit head to replace Garijo as CEO Merck KGaA's CEO Belén Garijo will step down next year and will be replaced by the group's electronics boss Kai Beckmann.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.